Perrigo Company plc Stock price

Equities

PRGO

IE00BGH1M568

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-01 pm EST 5-day change 1st Jan Change
26.33 USD +0.27% Intraday chart for Perrigo Company plc -18.10% -18.18%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 4.65B Sales 2025 * 4.88B Capitalization 3.57B
Net income 2024 * -35M Net income 2025 * 102M EV / Sales 2024 * 1.45 x
Net Debt 2024 * 3.16B Net Debt 2025 * 2.91B EV / Sales 2025 * 1.33 x
P/E ratio 2024 *
-70.2 x
P/E ratio 2025 *
59.8 x
Employees 8,900
Yield 2024 *
4.19%
Yield 2025 *
4.45%
Free-Float 99.04%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.27%
1 week-18.10%
Current month+0.27%
1 month-18.43%
3 months-14.79%
6 months-27.16%
Current year-18.18%
More quotes
1 week
25.77
Extreme 25.77
32.36
1 month
25.77
Extreme 25.77
32.57
Current year
25.77
Extreme 25.77
34.60
1 year
25.77
Extreme 25.77
40.28
3 years
25.77
Extreme 25.77
50.90
5 years
25.77
Extreme 25.77
63.86
10 years
25.77
Extreme 25.77
215.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 23-06-29
Director of Finance/CFO 49 22-05-15
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Chairman 55 20-12-14
Director/Board Member 68 17-02-05
Director/Board Member 67 17-02-05
More insiders
Date Price Change Volume
24-03-01 26.33 +0.27% 5,798,761
24-02-29 26.26 -0.57% 5,290,128
24-02-28 26.41 -3.26% 6,364,104
24-02-27 27.3 -15.14% 10,621,771
24-02-26 32.17 +0.06% 2,160,474

Delayed Quote Nyse, March 01, 2024 at 04:00 pm EST

More quotes
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
26.33 USD
Average target price
38.75 USD
Spread / Average Target
+47.17%
Consensus
  1. Stock
  2. Equities
  3. Stock Perrigo Company plc - Nyse
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW